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Abstract 
 Antibody phage display has become a useful technique for discovering and optimizing target-specific 
monoclonal antibodies suitable for many applications, including therapeutic ligands, which may act as direct 
pharmacological compounds or may be used as targeting ligands for controlled drug delivery. Recently, the                   
D2-5-HT1A heteromer, which is formed by the dopamine D2 and serotonin 5-HT1A receptors has attracted 
attention as a potential target of antipsychotic drugs. Therefore, the aim of the study was to identify scFv 
monoclonal antibodies that are able to specifically recognize epitopes formed within the heteromer structure. 
Because both receptors are membrane proteins, it is important to conduct bio-panning experiments in the most 
natural conditions, in which the presented antigens (D2-5-HT1A heteromers) are in their native form and possibly 
in their best-preserved spatial structure. It has been shown here that phage display methodology can be 
successfully used in the preparation of monoclonal antibodies against dimers of membrane proteins. To separate 
phages specifically binding the D2-5-HT1A heteromer, the selection process using CHO+ cells with overexpression 
of both receptors was conducted. Phages that were bound to receptor monomers or other CHO-K1 cell surface 
proteins were eliminated as a result of negative selection by using CHO- cells expressing separate receptor 
monomers. 
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Introduction 
 Nanoparticulate systems with functionalized 
surfaces for targeted drug delivery play central roles in 
modern therapies [1,2,3]. In our previous studies, we 
focused on the encapsulation of clozapine (one of the 
most important antipsychotic drugs) into biocompatible 
polymeric nanocapsules formed by polyelectrolyte 
multilayer shells [4,5]. Promising nanocarriers able                    
to cross the blood brain barrier (BBB) were                      
obtained [6]; however, to achieve higher selectivity, 
additional functionalization of the nanocarrier is needed. 
This necessity is well exemplified by clozapine, which is 
effectively used in the clinic; however, clozapine displays 
many serious side effects that most likely could be 
eliminated if we knew the precise mechanism 
responsible for its efficacy. Recently, we have shown 
that heteromers formed by the dopamine D2 and 
serotonin 5-HT1A receptors (D2R and 5-HT1AR, 
respectively) might be important site of action of 
clozapine [7]. Using the conventional route of 
administration, this drug (as well as other 
antipsychotics), addressed only for a small part of the 
cell population in the brain,  is non-specifically delivered 
into all brain areas, causing undesirable side effects. 
Higher selectivity may be achieved using compounds 
directly targeting D2-5-HT1A heteromers because these 
heteromers can be formed only on neurons                             
co-expressing receptors engaged in the complex 
formation. 
 Human monoclonal scFv (single-chain variable 
fragment) antibodies may be used as targeting ligands 
to decorate the outer surface of nanovehicles. ScFvs are 
small antibody fragments that compose the variable 
regions of the heavy (VH) and light (VL) chains of 
immunoglobulins with a flexible peptide linker designed 
to connect the two chains in such a way that the           
antigen binding site is retained in a single co-linear 
molecule [8]. ScFvs can be obtained from phage display 
libraries [9,10]. ScFvs have the potential to be very 
useful for the targeted delivery of drugs to specific cells 
or tissues. In comparison to the much larger Fab, F(ab)2, 
and IgG forms of monoclonal antibodies, from which 
they are derived, scFvs have lower retention times in 
non-target tissues, faster blood clearance, better tissue 
penetration and reduced immunogenicity, making them 
attractive for therapeutic applications [11]. 
 Therefore, in the present study, we focused on 
the production of an scFv antibody that specifically binds 
the D2-5-HT1A heteromer. The antibody should be able 
to recognize the heteromer formed by both receptors, 
and it should not recognize the monomeric forms of the 
receptors. The obtained antibody would be used to 
modulate the surface properties of nanocapsules, which 
could then be exploited as a novel nanocarrier of 
antipsychotics. In this way, we can obtain efficient 
delivery of the encapsulated drugs preferentially to the 
defined site in selective tissues. To produce specific scFv 
antibodies with defined a D2-5-HT1A heteromer 
selectivity, the antibody phage display libraries 
Tomlinson I+J was used. The library allows us to obtain 
approximately 3x108 various filamentous phages with 
the relevant fusion protein PIII-scFv (coding by 
phagemid pIT2) as part of their coat. The bio-panning 
process was conducted in a CHO-K1 cell line expressing 
the desired receptors. 
Materials and Methods 
Cell Culture and Transfection 
 CHO-K1 cells (ATCC) were grown in RPMI 
(Sigma) medium supplemented with 10%                           
heat-inactivated fetal bovine serum (FBS) (Sigma). The 
TurboFect reagent (Thermo Sci.) was used for transient 
and stable transfections. The procedure was carried out 
in accordance with the manufacturer’s protocol. Early 
passages of CHO-K1 cells were stably transfected                    
(1.5 mg DNA) with the plasmid pcDNA3.1(+) encoding 
the human 5-HT1AR or the human D2R (UMR cDNA 
Resource Centre) separately or cotransfected with both 
vectors. Stable cell lines expressing D2R and/or 5-HT1AR 
were obtained after the addition of the selection 
antibiotic, G418 (Sigma), at a final concentration of 0.75 
mg/ml. Cells resistant to the antibiotic and stably 
expressing investigated receptors were analysed by                  
RT-PCR (data not shown). Forty-eight hours before the 
selection experiment, stable cell lines were transiently 
transfected with 0.5 mg DNA (per 10 mm plate area) 
encoding the desired receptors. Additionally, the                  
HEK-293 cell line (ATCC) was used. The cells were 
grown in MEM (Sigma) supplemented with 1%                          
L-glutamine and 10% heat-inactivated FBS (Sigma). 
 All cells were cultured at 37°C inside a 
humidified incubator in an atmosphere of 5% CO2. 
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Screening of Phage-Displayed scFv Libraries 
 The human antibody scFv phagemid library 
Tomlinson I+J (Geneservice) was used. The library J  
was amplified and titrated according to the 
manufacturer’s protocols using E. coli TG1 cells. 
Biopanning was conducted against the D2-5-HT1A 
heteromer using CHO-K1 cells expressing D2-5-HT1A 
heteromers(CHO-positive cells; CHO+) and CHO-K1 cells 
expressing D2R mixed with CHO-K1 cells expressing                
5-HT1AR (1:1) (CHO-negative cells; CHO-). Five rounds 
of positive selection followed by negative preselection 
and finally 2 negative selections were performed. 
Preselection was performed as follows: amplified phages 
were blocked for 2 hr at RT (or overnight at 4°C) in 3% 
MPBS and then added to culture medium with CHO- cells 
grown on 150 mm plates (20x, 95% confluence) and 
incubated for 2 hr at 0°C. Then, the temperature was 
changed to 37°C for 20 min. The CHO- cells were 
centrifuged (10 min at 1000 rpm), and the supernatant 
containing unbound phages was added to the medium 
with CHO+ cells grown on 150 mm plates (10x, 95% 
confluence). From that moment, the positive selection 
began and extended for 2 hr at 0°C. In the next step, 
the cells were washed 4 times with cold PBS. Between 
washings, RPMI medium was added, and the cells were 
incubated on ice for 10 min. Similar to preselection, for 
the next 20 min, the temperature of incubation was 
changed to 37°C. In the next step, the cells were 
washed 4 times using elution buffer (100 mM glycine, 
150 mM NaCl, pH 2.8). The number of washes increased 
(twice each time) with subsequent rounds of selection. 
Finally, CHO+ cells were harvested from the plates and 
resuspended in PBS containing trypsin (1 mg/ml) for 
approximately 15 min (until cell lysis). Then, the 
obtained suspension was centrifuged (10 min, 1000 
rpm, 4°C), and the supernatant containing the desired 
phages after titration and amplification was used for 
another round of biopanning. The biopanning rounds 
were repeated until the results of polyclonal phages 
ELISA related to output phages reached a plateau or 
started to decline. 
Polyclonal Phage ELISA 
 The efficiency of the biopanning process was 
determined using polyclonal phage ELISA. A total of 50 
ml of amplificated phages (obtained after each round of 
selection) was added to each well of the 96-well                     
V-microtiter plate (Sarstedt) and incubated with 50 ml of 
4% MPBS for 2 hr at 37°C. Then, 1.5 x105 CHO+ cells 
(resuspended in 50 ml of RPMI with 5% FBS) expressing 
D2-5-HT1A heteromers (positive probe) were added to 
the wells with blocked phages and incubated on ice for 1 
hr. The negative probe consisted of CHO- cells, i.e., cells 
expressing a single type of receptor mixed at the 1:1 
ratio. The washing step was conducted 3 times at 4°C 
using 200 ml cold PBS. After each round, the cells were 
centrifuged (300 x g, 10 min, 4°C), and the supernatant 
was rejected. Bound phages were detected using 
horseradish peroxidase (HRP)-conjugated anti-M13 
monoclonal antibodies (GE Healthcare). Briefly, after 
washing, the cells were incubated with the antibody 
resuspended in a 1:5000 ratio in 3% MPBS for 30 min 
on ice and then washed 4 times as described above. 
Finally, 100 ml of TMB substrate (GE Healthcare) was 
added to each well. The reaction was stopped with 1 M 
HCl (100 ml per well), and the absorbance was 
measured at 450 nm. Experiments were performed in 
triplicate. 
Monoclonal Phage ELISA 
 Based on the results of polyclonal phage ELISA, 
phage clones from rounds characterized by the highest 
affinity against CHO+ cells were randomly selected for 
monoclonal phage ELISA experiments. Individual 
colonies were inoculated into 96-well plates containing 
100 ml 2xTYAG (2xTY (Bioshop) with 100 μg/ml 
ampicillin (Sigma) and 1% glucose (Bioshop)) medium 
per well and cultured overnight at 37°C (250 rpm). 
Then, 5 ml of the culture (from each well) was added to 
fresh 200 ml 2xTYAG medium and cultured with shaking 
(250 rpm) at 37°C for 2 hr. After that time, 109 helper 
phages were added to the wells and incubated for 1 hr 
and at 37°C with shaking at 250 rpm. The plates were 
then centrifuged (1800 x g, 10 min), the supernatants 
were aspirated off, and bacterial pellets were 
resuspended in 200 ml 2xTYAKG (2xTY containing 100 
μg/ml ampicillin, 50 mg/ml kanamycin (Sigma) and 1% 
glucose) medium and incubated overnight at 30°C (250 
rpm). Finally, the plates were centrifuged (1800 x g, 10 
min), and 50 ml of supernatants (containing monoclonal 
phages) was used in the phage ELISA as described 
above (2.4). 
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ScFv Expression in the Bacterial System 
 To obtain soluble scFv expressed in E. coli 
HB2151, a single colony was used to inoculate 5 ml of 
2xTY medium containing 100 μg/ml ampicilin, and the 
cultures were grown overnight at 37°C. A total of 2.5 ml 
of the overnight culture was used to inoculate 25 ml, 
and then this culture was used to start a 1 L culture at 
37°C. The expression was induced in the host bacteria 
by adding IPTG to the final concentration of 1 mM when 
the OD600 reached 0.9; the incubation continued for 16 
h at 28°C, and then the cells were harvested by 
centrifugation (4000 x g, 15 min, 4°C). The cells were 
placed on ice until scFv purification. 
Large-Scale Purification of Soluble scFv Fragments 
 ScFvs are secreted into the periplasmic space 
located between the outer and inner membrane of E. 
coli. The pellet of bacterial cells was resuspended in 
buffer consisting of 50 mM Tris-HCl (Bioshop), pH 8.0; 
20% sucrose (Bioshop); 1 mM EDTA (Bioshop); and 1x 
Protease Inhibitor Cocktail (Sigma) using 20 ml buffer/1 
L overnight culture). The cells were incubated on ice for 
15 min with gentle agitation, and then the cell 
suspension was centrifuged at 30000 x g for 30 min at 
4°C. The supernatant is the osmotic shock fluid 
containing periplasmic proteins and was divided into two 
equal parts: one was dialyzed extensively against Protein 
L Binding Buffer (100 NaH2PO4, pH 7.2; 150 mM NaCl) 
(Bioshop). The dialysis was carried out at 4°C overnight 
before continuing with the purification. The supernatants 
were centrifuged (30000 x g, 30 min, 4°C) after dialysis. 
ScFvs were purified at room temperature. 
 The extract of E. coli scFvs was loaded onto a 
column filled with 5 ml of Protein L Agarose equilibrated 
with Protein L Binding Buffer at a flow rate of 1 ml/min. 
After washing with 10 column volumes of Binding Buffer, 
the proteins were eluted from the column with Elution 
Buffer that contained 0.1 M glycine, pH 2.5 (at flow rate 
1 ml/min). Eluted fractions were immediately adjusted to 
physiologic pH by adding 100 μl of the Neutralization 
Buffer (1 M Tris, pH 8.0) to 1 ml of eluate. Fractions 
containing scFvs (as judged by SDS-PAGE and 
Coomassie Brilliant Blue staining) were pooled and 
dialyzed against 1x PBS at 4°C overnight. The 
concentration of protein was calculated via Bradford 
assay. The purified fractions were stored at -80°C. 
SDS-PAGE 
 Samples for analysis were mixed with 2x 
Electrophoresis Buffer containing 50 mM Tris-HCl, pH 
6.8; 10% glycerol; 2% SDS; 0.1% bromophenol blue 
and 5% β-mercaptoethanol and heated for 5 min at 95°
C. SDS-PAGE was performed according to Laemmli, 
1970 [12] with a 4% stacking gel and a 12% resolving 
gel (Mini-Protean 3, Bio-Rad). Gels were stained by 
Coomassie Brilliant Blue. 
Analysis of Specificity of Obtained scFvs Monoclonal 
Antibodies 
 The specificity of purified scFvs was determined 
by ELISA and flow cytometry analysis. In the case of the 
ELISA experiments, 100 ml of purified antibodies at 
different concentrations, resuspended in 4% BSA, were 
added to wells of a 96-V-well plate and incubated for 1.5 
h at 37°C. Then, 1.5 x105 CHO+ cells as well as                    
CHO- cells (resuspended in 50 ml of RPMI with 5% FBS) 
were added to the suitable well with blocked antibodies 
and incubated on ice for 1 hr. The washing step was 
conducted 3 times at 4°C using 200 ml cold PBS. After 
each round, the cells were centrifuged (300 x g, 10 min, 
4°C), and the supernatant was aspirated off. Then, the 
pellets were resuspended in 50 ml protein L conjugated 
with HRP (protein L was resuspended in 0.5% BSA/PBS, 
1:2000 ratio) and incubated for 30 min on ice. After 
washing (carried out 4 times as described above), the 
reactions were developed by TMB substrate. 
Experiments were performed in triplicate. 
 Moreover, similar experiments were conducted 
with HEK-293 cells. HEK-293+ represents cells stably 
expressing D2R and 5-HT1AR, HEK-293- represents a 
mixture of HEK-293 cells expressing individual forms of 
the receptors. 
 Before experiments using flow cytometry 
analysis, purified antibodies were conjugated with 
fluorescent dye. The idea of the tests was the same as 
described above in the case of ELISA. The same types of 
cells were used. The experiments were conducted to 
confirm the results from ELISA. 
Results and Discussion 
 Phage display is a powerful tool for the 
identification of peptides, proteins or antibodies with 
affinity for a specific target [13]. The advantage of the 
method is the possibility of the production of monoclonal 
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antibodies recognizing antigens that cannot be used to 
immunize an animal due to their toxicity,                             
non-immunogenicity or presence in complexes on the 
surface of cell membranes [14]. Therefore, in the 
present study, we used a phage display technique to 
prepare a novel human monoclonal scFv antibody that 
specifically recognized the D2-5-HT1A heteromer. To 
obtain such properties, the antibody should recognize 
the structural, spatial epitope formed within the 
heteromer structure. Both receptors mentioned above 
are membrane proteins belonging to the GPCR family. 
Therefore, it was impossible to perform a selection 
process using recombinant antigen since obtaining such 
an antigen in a soluble form with the correct spatial 
structure is too difficult to achieve in the case of 
membrane proteins. 
 In the present study, to separate phages 
specifically binding to the D2-5-HT1A heteromer, the 
selection process using CHO+ cells with overexpression 
of both investigated receptors was conducted. Phages 
that were bound to receptor monomers or other CHO-K1 
cell surface proteins were eliminated as a result of 
negative selection by using CHO- cells expressing 
separate receptor monomers. To increase the density of 
receptors on the surface of CHO-K1 cells, the stable cell 
lines were additionally transiently transfected with 
plasmids encoding receptors of interest. The cells of the 
CHO-K1 cell line are very useful in such experiments 
since they are easy to culture and are susceptible to 
transfection; they do not express D2R or 5-HT1AR 
endogenously, which is a very important issue because it 
provides the opportunity to modulate the density of the 
receptors on the cell surface. The biopanning process 
was based on library phages interacting with the antigen 
formed on the cell surface by the D2-5-HT1A heteromer. 
The process was performed on cells growing on the 
plate surface. The process provided the best conditions 
for the formation of the spatial D2-5-HT1A antigen and 
minimized the risk of isolation of antibodies that 
recognize undesired antigens [15]. Several parameters 
affect biopanning efficiency, including antigen 
concentration, temperature, washing stringency 
(washing number and composition of wash buffer) as 
well as blocking and elution buffer composition [16]. 
 Elimination of nonspecific binding without             
losing rare specific clones remains a serious                  
challenge [16]. Therefore, in the present study, we 
decided to perform negative preselection in each round 
of biopanning. Finally, after 5 full rounds (preselection 
and positive selection), 2 negative rounds were 
conducted. During each round, after incubation at 0°C, 
the temperature was changed to 37°C. It induces the 
internalization process. In our previous studies, the 
different kinds of selections were tested, and the highest 
level of phage enrichment was observed in the case of 
isolation of phages after the internalization of receptors 
serving as the desired antigen (unpublished results). 
 The selection process was assessed by 
monitoring the enrichment ratio and polyclonal phage 
ELISA. The increasing titre of phages indicates the 
correctness of the bio-panning process and corresponds 
with the enrichment of phages that specifically 
recognized the D2-5-HT1A heteromer (Fig 1). In the initial 
rounds, the difference in polyclonal phages binding to 
Figure 1. Monitoring of bio-panning process. A) Titre of phages after each selection rounds; B)                
Enrichment of phages that specifically recognized the D2-5-HT1A heteromer – polyclonal phage                 
ELISA. 
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CHO+ vs. CHO- cells was small, while after the 4th and 
5th round, the positive signal was more than 8 times 
higher . 
 After the selection process, the specific binding 
of individual monoclonal phages to CHO+ cells was 
tested by ELISA techniques. Experiments were 
performed using CHO+, CHO- and CHO-K1 cells.     
Twenty-six phages of 960 tested exhibited high levels of                  
D2-5-HT1A heteromer specificity (Table 1).  
 Among originally selected phages, satisfactory 
expression could be obtained only for 12 clones. This 
was due to the presence of STOP codons within the 
sequence of DNA encoding the antibodies (data not 
shown). Four phages possessing the best parameters 
were used for the infection of bacterial cells HB2151 (E. 
coli) and the production of soluble monoclonal scFv 
antibodies. The expression level was monitored by SDS 
PAGE electrophoresis. The antibodies were obtained 
from periplasmic extract and purified by affinity 
chromatography using Protein L-immobilized resin. 
 The activity of phage display-derived antibodies 
was determined using ELISA (Fig 2). The specificity of 
D2-5-HT1A heteromer recognition of 4 soluble scFv 
fragments was tested using CHO+, CHO-, CHO-K1 cells 
as well as CHO-K1 cells expressing different                      
GPCR - somatostatin receptor type 1 (Sst1). Additionally, 
similar tests were conducted using HEK-293+,                      
HEK-293-, and HEK-293 cells. Similar results were 
recorded using flow cytometry techniques (data not 
shown). Based on the results, the 1H/5r1 antibody 
exhibits the most promising properties. 
 In conclusion, it has been shown here that 
phage display methodology can be successfully used in 
the preparation of monoclonal antibodies against 
membrane proteins. In the present study, a novel 
human monoclonal scFv antibody, which specifically 
recognized the heteromer formed by D2R and 5-HT1AR 
and simultaneously did not bind to the monomeric forms 
scFv name 
CHO-K1 
[R] 
 CHO- 
[R] 
1F/5r1 3.87 3.62 
4C/5r1 3.67 3.35 
5E/5r1 4.44 4.67 
1G/5r1 46.21 41.83 
10G/5r2 18.81 16.82 
4H/5r2 2.83 2.56 
6H/5r2 16.87 16.32 
4D/5r3 2.23 2.31 
5D/5r3 2.98 2.27 
8H/5r3 4.21 4.32 
2D/5r4 22.57 23.86 
6C/5r5 5.27 4.37 
Table 1. Binding level of 12 various monoclonal phages specific to                       
D2-5HT1A heteromer (CHO+ cells) in relation to: CHO-K1, CHO- cells –     
determined by ELISA technique. 
[R] –ratio of positive (absorbance 450nm CHO+ cells) vs negative signal 
(absorbance 450nm CHO-K1, CHO- cells, respectively). 
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of the receptors, was isolated. In the future, to obtain 
the best parameters of antigen-antibody interaction, the 
modifications of selected antibodies will be conducted 
using random mutagenesis. Eventually, the obtained 
antibody would be used as a targeting ligand to 
functionalize the surface of nanocapsules, which would 
then be exploited as a novel nanocarrier of 
antipsychotics.  
Acknowledgments 
 The manuscript has been corrected by AJE - 
Certificate Verification Key 7E03-CDAE-8EC3-6773-9BB7. 
The Faculty of Biochemistry, Biophysics and 
Biotechnology is partner with the Leading National 
Research Centre (KNOW) supported by the Ministry of 
Science and Higher Education. This work was supported 
by grants 35+ Nr. 35p/1/2016 from KNOW. The work 
was also co-financed from European Union within 
Regional Development Fund - Grants for innovation – 
PARENT/BRIDGE Programme - POMOST/2011-4/5.  
Conflict of Interest 
 The authors report no conflicts of interest in this 
work. The authors also declare no competing financial 
interest. 
References 
1. R.S. Kadam, D.W. Bourne, U.B. Kompella,               
Nano-advantage in enhanced drug delivery with 
biodegradable nanoparticles: contribution of reduced 
clearance, Drug Metab. Dispos. 40 (2012)                         
1380-1388. doi: 10.1124/dmd.112.044925 
2. V. Bourganis, T. Karamanidou, O. Kammona, C. 
Kiparissides, Polyelectrolyte complexes as 
prospective carriers for the oral delivery of protein 
therapeutics, Eur. J. Pharm. Biopharm. 111 (2017) 
44-60. doi: 10.1016/j.ejpb.2016.11.005 
3. K. Szczepanowicz, U. Bazylinska, J. Pietkiewicz, L. 
Szyk-Warszynska, K.A. Wilk, P. Warszynski, 
Biocompatible long-sustained release oil-core 
polyelectrolyte nanocarriers: From controlling 
physical state and stability to biological impact, Adv. 
Colloid Interface Sci. 222 (2015) 678-691. doi: 
10.1016/j.cis.2014.10.005 
4. S. Łukasiewicz, K. Szczepanowicz, K. Podgórna, E. 
Błasiak, N. Majeed, S.O.Ö. Ogren, W. Nowak, P. 
Warszyński, M. Dziedzicka-Wasylewska, 
Encapsulation of clozapine in polymeric 
nanocapsules and its biological effects, Colloids Surf. 
B Biointerfaces. 140 (2016) 342-352. doi: 10.1016/
j.colsurfb.2015.12.044. 
5. S. Łukasiewicz, K. Szczepanowicz, E. Błasiak, M. 
Dziedzicka-Wasylewska, Biocompatible Polymeric 
Nanoparticles as Promising Candidates for Drug 
Delivery, Langmuir. 31 (2015) 6415-6425. doi: 
10.1021/acs.langmuir.5b01226 
6. S. Łukasiewicz, E. Błasiak, K. Szczepanowicz, K. 
Guzik, M. Bzowska, P. Warszyński, M.                      
Figure 2. Phage display-derived scFv antibodies. A) SDS-PAGE electrophoresis after protein purifica-
tion; B) D2-5-HT1A heteromer specificity of isolated scFvs antibodies determined using ELISA tech-
nique (y axis – ratio of positive vs negative signal). 
 Freely Available  Online 
www.openaccesspub.org       JNDC        CC-license       DOI :  10.14302/issn.2377-2549.jndc-19-2736                Vol-2 Issue-3 Pg. no.–  25  
Dziedzicka-Wasylewska, The interaction of clozapine 
loaded nanocapsules with the hCMEC/D3 cells - In 
vitro model of blood brain barrier, Colloids Surf B 
Biointerfaces. 159 (2017) 200-210. doi: 10.1016/
j.colsurfb.2017.07.053. 
7. S. Łukasiewicz, E. Błasiak, K. Szafran-Pilch, M. 
Dziedzicka-Wasylewska, Dopamine D2 and serotonin 
5-HT1A receptor interaction in the context of the 
effects of antipsychotics - in vitro studies, J 
Neurochem. 137 (2016) 549-560. doi: 10.1111/
jnc.13582 
8. R.E. Bird, K.D. Hardman, J.W. Jacobson, S. Johnson, 
B.M. Kaufman, S.M. Lee, T. Lee, S.H. Pope, G.S. 
Riordan, M. Whitlow, Single- chain antigen-binding 
proteins, Science 242 (1988) 423–426. 
9. C.F. Barbas, Phage display: a laboratory manual. 
Cold Spring Harbor, NY: Cold Spring Harbor 
Laboratory Press; 2001. 
10. C.M. Lee, N. Iorno, F. Sierro, D. Christ, Selection of 
human antibody fragments by phage display, Nat 
Protoc. 2 (2007) 3001–3008. doi: 10.1038/
nprot.2007.448 
11. A. Frenzel, M. Hust, T. Schirrmann, Expression of 
recombinant antibodies. Front Immunol. 4 (2013)                     
1-20. doi: 10.3389/fimmu.2013.00217 
12. U.K. Laemmli, Cleavage of structural proteins during 
the assembly of the head of bacteriophage T4, 
Nature 227 (1970) 680–685. 
13. P.A. Hoen, S.M. Jirka, B.R. Ten Broeke, E.A. 
Schultes, B. Aguilera, K.H. Pang, H. Heemskerk, A. 
Aartsma-Rus, G.J. van Ommen, J.T. den Dunnen, 
Phage display screening without repetitious selection 
rounds, Anal Biochem. 421 (2012) 622-631. doi: 
10.1016/j.ab.2011.11.005. 
14. P. Pansri, N. Jaruseranee, K. Rangnoi, P. Kristensen, 
M. Yamabhai, A compact phage display human scFv 
library for selection of antibodies to a wide variety of 
antigens, BMC Biotechnol. 9 (2009) 1-16. doi:  
10.1186/1472-6750-9-6  
15. E. Pavoni, P. Vaccaro, A.M. Anastasi, O. Minenkova,  
Optimized selection of anti-tumor recombinant 
antibodies from phage libraries on intact cells. Mol 
Immunol. 57 (2014) 317-322.  doi: 10.1016/
j.molimm.2013.10.009. 
16. L. Rahbarnia, S. Farajnia, H. Babaei, J. Majidi, K. 
Veisi, A. Tanomand, B. Akbari, Invert biopanning: A 
novel method for efficient and rapid isolation of 
scFvs by phage display technology, Biologicals. 44 
(2016) 567-573. doi: 10.1016/
j.biologicals.2016.07.002. 
 
